A detailed history of Nisa Investment Advisors, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 5,309 shares of TGTX stock, worth $164,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,309
Previous 5,419 2.03%
Holding current value
$164,950
Previous $96,000 29.17%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$17.21 - $25.28 $1,893 - $2,780
-110 Reduced 2.03%
5,309 $124,000
Q2 2024

Jul 19, 2024

BUY
$13.32 - $19.19 $1,371 - $1,976
103 Added 1.94%
5,419 $96,000
Q1 2024

May 01, 2024

BUY
$13.02 - $21.3 $1,770 - $2,896
136 Added 2.63%
5,316 $80,000
Q4 2023

Jan 25, 2024

SELL
$6.68 - $18.81 $301,268 - $848,331
-45,100 Reduced 89.7%
5,180 $88,000
Q3 2023

Nov 02, 2023

SELL
$8.36 - $26.5 $299,288 - $948,700
-35,800 Reduced 41.59%
50,280 $420,000
Q2 2023

Aug 11, 2023

SELL
$15.48 - $35.0 $312,696 - $707,000
-20,200 Reduced 19.01%
86,080 $2.14 Million
Q1 2023

May 02, 2023

BUY
$10.23 - $19.34 $314,674 - $594,898
30,760 Added 40.73%
106,280 $1.6 Million
Q4 2022

Feb 02, 2023

BUY
$5.01 - $11.83 $327,153 - $772,499
65,300 Added 638.94%
75,520 $893,000
Q3 2022

Nov 07, 2022

BUY
$4.57 - $8.4 $40,988 - $75,339
8,969 Added 716.95%
10,220 $59,000
Q2 2022

Aug 03, 2022

SELL
$3.74 - $10.66 $278,256 - $793,104
-74,400 Reduced 98.35%
1,251 $5,000
Q1 2022

Apr 29, 2022

BUY
$7.81 - $20.45 $444,389 - $1.16 Million
56,900 Added 303.45%
75,651 $719,000
Q4 2021

Feb 03, 2022

SELL
$15.2 - $35.51 $121,083 - $282,872
-7,966 Reduced 29.82%
18,751 $217,000
Q3 2021

Oct 18, 2021

BUY
$21.78 - $40.45 $1,350 - $2,507
62 Added 0.23%
26,717 $889,000
Q2 2021

Aug 06, 2021

BUY
$32.5 - $48.96 $9,750 - $14,688
300 Added 1.14%
26,655 $1.03 Million
Q1 2021

Apr 26, 2021

SELL
$41.61 - $54.3 $8,946 - $11,674
-215 Reduced 0.81%
26,355 $1.27 Million
Q4 2020

Jan 25, 2021

BUY
$25.27 - $54.9 $139,490 - $303,048
5,520 Added 26.22%
26,570 $1.38 Million
Q3 2020

Oct 20, 2020

BUY
$18.49 - $27.24 $49,922 - $73,548
2,700 Added 14.71%
21,050 $563,000
Q1 2020

Apr 17, 2020

SELL
$7.14 - $15.99 $535 - $1,199
-75 Reduced 0.41%
18,350 $181,000
Q4 2018

Jan 17, 2019

BUY
$3.44 - $5.76 $60,200 - $100,800
17,500 Added 1891.89%
18,425 $76,000
Q2 2018

Jul 19, 2018

BUY
$12.5 - $15.0 $5,000 - $6,000
400 Added 76.19%
925 $12,000
Q1 2018

Apr 10, 2018

SELL
$8.7 - $16.8 $5,872 - $11,340
-675 Reduced 56.25%
525 $7,000
Q4 2017

Jan 12, 2018

BUY
$7.35 - $12.3 $1,470 - $2,460
200 Added 20.0%
1,200 $10,000
Q3 2017

Oct 13, 2017

BUY
$10.0 - $12.7 $10,000 - $12,700
1,000
1,000 $12,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.51B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.